<p>(A) C57BL/6 mice were primed with PBS or anti-DEC:OVA+anti-CD40, and boosted with anti-DEC:OVA+anti-CD40 at day 60. At day 2, 4, and 7 after booster immunization, splenocyes were isolated, labeled with CFSE, and then cultured without (B) or with (C) OVA(257-264) peptide. 3 days after in vitro culture, OVA-specific CD8<sup>+</sup> T cell proliferation was examined by staining splenocytes with anti-CD8 and K<sup>b</sup>/OVA257-264 tetramer. (B) Autonomous proliferation of OVA-specific T cells in the absence of OVA peptide. Plots were gated on CD8<sup>+</sup> cells. Numbers indicate the percentage of tetramer<sup>+</sup> cells in CD8<sup>+</sup> cells. (C) Ag-driven proliferation of OVA-specific T cell in the presence of OVA-peptide. Plots ...
<p>WT or <i>Hvem</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and the am...
<p>(A) Schematic of i.n. prime/boost experiment. (B and C) Immunodomination of naïve CD8<sup>+</sup>...
<p>Transgenic OVA-specific CD8<sup>+</sup> T cells (A-i) and OVA-specific CD4<sup>+</sup> T cells (B...
<p>Mice were primed with PBS or anti-DEC:OVA+anti-CD40, and boosted with anti-DEC:OVA+anti-CD40 at d...
<p>(A) In vivo CTL activity. C57BL/6 mice were primed with PBS or anti-DEC:OVA+anti-CD40, and booste...
<p>(A) OVA(257-264) peptide-pulsed or unpulsed DCs were cultured with OT-I transgenic CD8<sup>+</sup...
<p>Mice primed with Lm-OVA were boosted 21 days later with the indicated dose of Lm-OVA. 5 days post...
<p>A. CD40-B cell vaccination generates CD8<sup>+</sup> Te cells but not Tm cells. 10<sup>6</sup> fe...
<p>(<b>A</b>) B6 or SM-Ova mice were immunized with rAAV-Ova, replicative VSV-Ova or live Lm-Ova. Se...
<p>Splenocytes from DNA-PolyEp-immunized or naive mice were labeled with CFSE and stimulated for 48 ...
<p>Splenic CD11c+ cells (2×10<sup>5</sup>) purified from C57BL/6 mice were incubated with BV-WT, BV-...
<p>(A) The frequency of OVA- and B8R-specific CD8 T cells were detected for the indicated groups fro...
<p>Specific cellular immune responses were analyzed at 10, 30 or 53 days after the immunization in g...
<p>(A) Experimental scheme. Naïve OVA-specific CD8 T cells were purified from WT or HVEM<sup>−/−</su...
<p>A- WT and <i>Btla</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and 7 ...
<p>WT or <i>Hvem</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and the am...
<p>(A) Schematic of i.n. prime/boost experiment. (B and C) Immunodomination of naïve CD8<sup>+</sup>...
<p>Transgenic OVA-specific CD8<sup>+</sup> T cells (A-i) and OVA-specific CD4<sup>+</sup> T cells (B...
<p>Mice were primed with PBS or anti-DEC:OVA+anti-CD40, and boosted with anti-DEC:OVA+anti-CD40 at d...
<p>(A) In vivo CTL activity. C57BL/6 mice were primed with PBS or anti-DEC:OVA+anti-CD40, and booste...
<p>(A) OVA(257-264) peptide-pulsed or unpulsed DCs were cultured with OT-I transgenic CD8<sup>+</sup...
<p>Mice primed with Lm-OVA were boosted 21 days later with the indicated dose of Lm-OVA. 5 days post...
<p>A. CD40-B cell vaccination generates CD8<sup>+</sup> Te cells but not Tm cells. 10<sup>6</sup> fe...
<p>(<b>A</b>) B6 or SM-Ova mice were immunized with rAAV-Ova, replicative VSV-Ova or live Lm-Ova. Se...
<p>Splenocytes from DNA-PolyEp-immunized or naive mice were labeled with CFSE and stimulated for 48 ...
<p>Splenic CD11c+ cells (2×10<sup>5</sup>) purified from C57BL/6 mice were incubated with BV-WT, BV-...
<p>(A) The frequency of OVA- and B8R-specific CD8 T cells were detected for the indicated groups fro...
<p>Specific cellular immune responses were analyzed at 10, 30 or 53 days after the immunization in g...
<p>(A) Experimental scheme. Naïve OVA-specific CD8 T cells were purified from WT or HVEM<sup>−/−</su...
<p>A- WT and <i>Btla</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and 7 ...
<p>WT or <i>Hvem</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and the am...
<p>(A) Schematic of i.n. prime/boost experiment. (B and C) Immunodomination of naïve CD8<sup>+</sup>...
<p>Transgenic OVA-specific CD8<sup>+</sup> T cells (A-i) and OVA-specific CD4<sup>+</sup> T cells (B...